Texas Permanent School Fund Decreases Position in Encompass Health Co. (NYSE:EHC)

Texas Permanent School Fund cut its holdings in Encompass Health Co. (NYSE:EHCGet Rating) by 1.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 70,535 shares of the company’s stock after selling 1,194 shares during the period. Texas Permanent School Fund owned approximately 0.07% of Encompass Health worth $5,016,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Covestor Ltd purchased a new stake in Encompass Health during the 4th quarter valued at about $38,000. Allworth Financial LP lifted its position in Encompass Health by 83.1% in the first quarter. Allworth Financial LP now owns 630 shares of the company’s stock valued at $45,000 after purchasing an additional 286 shares during the last quarter. Rather & Kittrell Inc. purchased a new stake in shares of Encompass Health during the fourth quarter valued at approximately $49,000. UMB Bank N A MO bought a new position in shares of Encompass Health in the fourth quarter worth approximately $59,000. Finally, MUFG Americas Holdings Corp bought a new position in shares of Encompass Health in the fourth quarter worth approximately $72,000. 91.70% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $52.91 on Friday. The business has a fifty day simple moving average of $54.14 and a two-hundred day simple moving average of $62.81. The firm has a market capitalization of $5.28 billion, a P/E ratio of 16.18, a P/E/G ratio of 2.54 and a beta of 0.91. The company has a current ratio of 1.24, a quick ratio of 1.26 and a debt-to-equity ratio of 1.29. Encompass Health Co. has a 12 month low of $44.33 and a 12 month high of $81.45.

Encompass Health (NYSE:EHCGet Rating) last posted its quarterly earnings data on Monday, August 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.97 by ($0.08). Encompass Health had a return on equity of 16.20% and a net margin of 6.22%. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the previous year, the firm earned $1.17 EPS. The company’s revenue was up 3.3% on a year-over-year basis. On average, equities analysts forecast that Encompass Health Co. will post 2.84 earnings per share for the current fiscal year.

Encompass Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health’s payout ratio is 34.25%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday. Raymond James dropped their target price on shares of Encompass Health from $70.00 to $65.00 and set a “strong-buy” rating for the company in a report on Thursday. Deutsche Bank Aktiengesellschaft reduced their price target on Encompass Health from $80.00 to $62.00 in a report on Wednesday. Credit Suisse Group dropped their price objective on Encompass Health from $83.00 to $82.00 and set an “outperform” rating for the company in a report on Friday, June 10th. Finally, Royal Bank of Canada reduced their target price on Encompass Health from $85.00 to $82.00 in a research note on Wednesday, June 8th. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Encompass Health currently has a consensus rating of “Buy” and an average target price of $74.60.

Encompass Health Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.